Mesenchymal Stem Cells Market Players:
- Bio-Techne Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Merck KGaA
- Genlantis, Inc.
- Celprogen Corporation
- PromoCell GmbH
- Cyagen US Inc.
- Plus Therapeutics, Inc.
- Human Longevity, Inc.
- Thermo Fisher Scientific Inc.
- Pluristem Therapeutics Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of mesenchymal stem cells is estimated at USD 4.33 billion.
The global mesenchymal stem cells market size was more than USD 3.87 billion in 2025 and is anticipated to grow at a CAGR of over 13.3%, reaching USD 13.49 billion revenue by 2035.
Asia Pacific mesenchymal stem cells market secures the largest share by 2035, driven by increasing healthcare awareness and rising prevalence of cancer and cardiovascular diseases.
Key players in the market include Bio-Techne Corporation, Merck KGaA, Genlantis, Inc., Celprogen Corporation, PromoCell GmbH, Cyagen US Inc., Plus Therapeutics, Inc., Human Longevity, Inc., Thermo Fisher Scientific Inc., Pluristem Therapeutics Inc.
